SNAP Asks Congress for Help in COVID-19 Relief Legislation (Letter)
SNAP has asked members of Pennsylvania’s congressional delegation for assistance in an end-of-the-year COVID-19 relief bill, including additional funding for the Provider Relief Fund, extension of the moratorium on the 2011 Medicare sequestration, and continued delay of implementation of Medicaid DSH cuts.
Governor Wolf has renewed his COVID-19 public health emergency declaration. See the announcement of the renewal
Pennsylvania’s number of COVID-19 cases today surpassed 375,000.
The Philadelphia Inquirer
The Department of State has extended until 90 days after the governor’s COVID-19 emergency declaration ends all temporary practice permits issued by the State Board of Nursing for RNs and PNs (licensees from other states who may or may not still need to be examined) and graduate temporary permits for RNs and PNs (graduates of nursing education programs who have yet to be examined) that were in effect on March 6, 2020 unless (1) the temporary practice permit holder was subsequently issued a license after March 6, 2020 or (2) the temporary practice permit holder subsequently failed the licensure examination after March 6, 2020. See the Department of State’s notice
The CDC has updated its
The GAO has examined the federal response to the COVID-19 public health emergency, describing the impact of the pandemic and the government’s response to it while identifying shortcomings in that response and recommending ways to address those shortcomings. Learn more from the GAO report “
Governor Wolf/Department of Health
Pennsylvania’s number of COVID-19 cases today surpassed 321,000.
HHS has announced plans to allocate doses of the investigational monoclonal antibody therapeutics casirivimab and imdevimab for treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19 at high risk of hospitalization; this is often referred to publicly as the Regeneron antibody cocktail. HHS will allocate 300,000 federally-purchased doses to state and territorial health departments that will determine which health care facilities receive the infusion drug. Weekly allocations of the drug will be proportionally based on confirmed COVID-19 cases in each state and territory over the previous seven days based on data that hospitals and state health departments enter into the HHS Protect data collection platform. Learn more from
The FDA has issued emergency use authorization for emergency use of baricitinib (Olumiant), in combination with remdesivir (Veklury), for use by health care professionals in the treatment of suspected or laboratory-confirmed COVID-19 in certain hospitalized patients requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). See
In the letter, SNAP wrote that
The report, “The 2020 State of Children’s Health Care in Pennsylvania: Unlocking Access to a Healthy Childhood,” includes the following major findings:
The Department of Health has released its “
The Provider Relief Fund web page has been
CMS has published
The CDC has published a